Treatment of human ovarian carcinoma A2780RCIS (ABCC2) and human gastric carcinoma EPG85-257RNOV (ABCG2) cell lines with this construct inhibited expression of the targeted encoding mRNA and protein itself [62,63]. This evidence concerns the gene ABCG2 and gastric carcinoma.